IS5035A - Aðferðir til varnar gegn brjóstakrabbameini - Google Patents

Aðferðir til varnar gegn brjóstakrabbameini

Info

Publication number
IS5035A
IS5035A IS5035A IS5035A IS5035A IS 5035 A IS5035 A IS 5035A IS 5035 A IS5035 A IS 5035A IS 5035 A IS5035 A IS 5035A IS 5035 A IS5035 A IS 5035A
Authority
IS
Iceland
Prior art keywords
prevention
methods
breast cancer
breast
cancer
Prior art date
Application number
IS5035A
Other languages
English (en)
Inventor
J. Cohen Frederic
S. Eckert Robert
E. Glusman Joan
K. Knickerbocker Ronald
T. Nickelsen Nikolaus
J. Scott Teri
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268608&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5035(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9624800.0A external-priority patent/GB9624800D0/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of IS5035A publication Critical patent/IS5035A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
IS5035A 1996-10-30 1999-04-27 Aðferðir til varnar gegn brjóstakrabbameini IS5035A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2985096P 1996-10-30 1996-10-30
GBGB9624800.0A GB9624800D0 (en) 1996-11-29 1996-11-29 Methods of preventing breast cancer
US4026097P 1997-03-10 1997-03-10
PCT/US1997/019779 WO1998018449A1 (en) 1996-10-30 1997-10-29 Methods of preventing breast cancer

Publications (1)

Publication Number Publication Date
IS5035A true IS5035A (is) 1999-04-27

Family

ID=27268608

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5035A IS5035A (is) 1996-10-30 1999-04-27 Aðferðir til varnar gegn brjóstakrabbameini

Country Status (44)

Country Link
US (2) US6303634B1 (is)
EP (3) EP0839532B1 (is)
JP (2) JPH10147530A (is)
CN (2) CN1182591A (is)
AP (1) AP971A (is)
AR (2) AR010538A1 (is)
AT (2) ATE338551T1 (is)
AU (3) AU5005697A (is)
BE (2) BE1011382A5 (is)
BG (1) BG63841B1 (is)
BR (1) BR9712703A (is)
CA (2) CA2219070C (is)
CH (2) CH693820A5 (is)
CZ (2) CZ341297A3 (is)
DE (2) DE69721692T2 (is)
DK (2) DK1369115T3 (is)
EA (2) EA006083B1 (is)
EE (1) EE03663B1 (is)
ES (4) ES2135343A1 (is)
FR (2) FR2755014B1 (is)
GB (3) GB2318733A (is)
GE (1) GEP20032910B (is)
GR (2) GR970100409A (is)
HK (1) HK1010495A1 (is)
HU (2) HUP9701778A3 (is)
IE (2) IE970772A1 (is)
IL (2) IL122026A0 (is)
IS (1) IS5035A (is)
IT (2) IT1298470B1 (is)
LU (2) LU90157B1 (is)
LV (1) LV12353B (is)
MY (1) MY121623A (is)
NL (2) NL1007386C2 (is)
NO (2) NO322468B1 (is)
NZ (1) NZ329042A (is)
PT (2) PT1369115E (is)
RO (1) RO120813B1 (is)
SG (2) SG83672A1 (is)
SI (3) SI0839532T1 (is)
SK (1) SK287047B6 (is)
TR (1) TR199900951T2 (is)
UA (1) UA46762C2 (is)
WO (2) WO1998018449A1 (is)
YU (1) YU42397A (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
GB9624800D0 (en) * 1996-11-29 1997-01-15 Lilly Co Eli Methods of preventing breast cancer
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
WO2002094788A1 (en) 2001-05-22 2002-11-28 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
US6962928B2 (en) 2001-05-22 2005-11-08 Eli Lilly And Company Tetrahydroquinoline derivatives for the inhibition of osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosis
US20040225200A1 (en) * 2003-05-09 2004-11-11 Edmundson Catherine M. System and method of analyzing the health of a population
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
CN102973573B (zh) * 2012-11-28 2015-04-08 玉林师范学院 一种人乳腺癌细胞抑制剂及制备方法
CN103830197A (zh) * 2014-03-14 2014-06-04 崔书豪 一种盐酸雷洛昔芬分散片及其制备方法
CN116650484A (zh) * 2023-05-11 2023-08-29 南通大学 一种乳腺癌相关蛋白的抑制剂及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
CZ253694A3 (en) * 1993-10-15 1995-05-17 Lilly Co Eli Pharmaceutical preparation for treating resistant neoplasms
BR9500758A (pt) * 1994-03-02 1995-10-24 Lilly Co Eli Formulaçoes farmacêuticas para administraçao oral
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
US5821254A (en) 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
DE69739855D1 (de) * 1996-03-26 2010-06-02 Lilly Co Eli Benzothiophene und denen enthaltende zusammensetzungen

Also Published As

Publication number Publication date
IE970773A1 (en) 2000-02-09
SK55999A3 (en) 2000-06-12
CZ300261B6 (cs) 2009-04-01
HUP9701778A2 (hu) 1999-01-28
EE9900162A (et) 1999-12-15
SI20107A (sl) 2000-06-30
AP9901494A0 (en) 1999-03-31
WO1998018325A1 (en) 1998-05-07
EA006083B1 (ru) 2005-08-25
NL1007387C2 (nl) 1998-05-14
EA002054B1 (ru) 2001-12-24
HUP9701778A3 (en) 1999-06-28
CZ341297A3 (cs) 1998-05-13
DE69721692D1 (de) 2003-06-12
CH691847A5 (fr) 2001-11-15
BG63841B1 (bg) 2003-03-31
ES2135342A1 (es) 1999-10-16
DE69736644T2 (de) 2007-10-25
GEP20032910B (en) 2003-03-25
EP0839533A1 (en) 1998-05-06
PT1369115E (pt) 2006-12-29
DE69721692T2 (de) 2004-03-25
CA2219070A1 (en) 1998-04-30
HUP9701777A2 (hu) 1999-06-28
NO322468B1 (no) 2006-10-09
SG83672A1 (en) 2001-10-16
LU90158B1 (fr) 1998-06-02
MX9708340A (es) 1998-08-30
US20020019418A1 (en) 2002-02-14
ES2135343A1 (es) 1999-10-16
AU5005697A (en) 1998-05-22
EP1369115A1 (en) 2003-12-10
AU4364897A (en) 1998-05-07
MY121623A (en) 2006-02-28
ITMI972434A1 (it) 1999-04-29
ATE239475T1 (de) 2003-05-15
GR970100409A (el) 1998-06-30
CH693820A5 (fr) 2004-02-27
NO974973D0 (no) 1997-10-28
LV12353A (lv) 1999-10-20
NZ329042A (en) 1999-08-30
BG103369A (en) 2000-05-31
AP971A (en) 2001-05-30
JPH10147530A (ja) 1998-06-02
US6303634B1 (en) 2001-10-16
AR013864A1 (es) 2001-01-31
CA2219070C (en) 2007-12-18
BE1011382A5 (fr) 1999-08-03
DK0839532T3 (da) 2003-08-25
UA46762C2 (uk) 2002-06-17
NO974972D0 (no) 1997-10-28
EP1369115B1 (en) 2006-09-06
CN1182591A (zh) 1998-05-27
DE69736644D1 (de) 2006-10-19
FR2755014B1 (fr) 1999-02-05
LV12353B (en) 2000-02-20
NO974972L (no) 1998-05-04
ATE338551T1 (de) 2006-09-15
SI1369115T1 (sl) 2006-12-31
GB2318734B (en) 1999-12-01
AU4364797A (en) 1998-05-07
FR2756490B1 (fr) 2003-06-20
HU9701777D0 (en) 1997-12-29
HU9701778D0 (en) 1997-12-29
FR2755014A1 (fr) 1998-04-30
SI0839532T1 (en) 2003-10-31
SK287047B6 (sk) 2009-10-07
ES2135342B1 (es) 2000-05-16
SG72765A1 (en) 2000-05-23
BE1011381A5 (fr) 1999-08-03
EA199900431A1 (ru) 1999-10-28
RO120813B1 (ro) 2006-08-30
EP0839532B1 (en) 2003-05-07
IL122025A (en) 2003-01-12
IE970772A1 (en) 2000-02-09
IL122026A0 (en) 1998-03-10
GB2318733A (en) 1998-05-06
AR010538A1 (es) 2000-06-28
NL1007386C2 (nl) 1998-05-14
AU731388B2 (en) 2001-03-29
GR970100408A (el) 1998-06-30
DK1369115T3 (da) 2007-01-02
EE03663B1 (et) 2002-04-15
ES2271476T3 (es) 2007-04-16
EA200100716A1 (ru) 2002-06-27
IL122025A0 (en) 1998-03-10
IT1298470B1 (it) 2000-01-10
EP0839532A1 (en) 1998-05-06
GB9911557D0 (en) 1999-07-21
FR2756490A1 (fr) 1998-06-05
CN1182590A (zh) 1998-05-27
WO1998018449A1 (en) 1998-05-07
HK1010495A1 (en) 1999-06-25
GR1003189B (el) 1999-09-01
HUP9701777A3 (en) 1999-07-28
JPH10147529A (ja) 1998-06-02
GB9722801D0 (en) 1997-12-24
ES2197312T3 (es) 2004-01-01
PT839532E (pt) 2003-09-30
CZ341197A3 (cs) 1998-05-13
LU90157B1 (fr) 1998-06-02
ITMI972433A1 (it) 1999-04-29
GB9722796D0 (en) 1997-12-24
BR9712703A (pt) 1999-10-26
CA2219377A1 (en) 1998-04-30
MX9708341A (es) 1998-08-30
TR199900951T2 (xx) 1999-07-21
AU5005197A (en) 1998-05-22
GB2318734A (en) 1998-05-06
YU42397A (sh) 2000-10-30

Similar Documents

Publication Publication Date Title
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
NO985765D0 (no) Kateterpakning
NO994069D0 (no) Forbindelser for immunoterapi av prostatacancer og fremgangsmåte for anvendelse derav
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
FI102474B1 (fi) Menetelmä moniarvoisten alkoholien valmistamiseksi
IS5035A (is) Aðferðir til varnar gegn brjóstakrabbameini
DK0942754T3 (da) Konjugater anvendelige til behandlingen af prostatacancer
DK0972024T3 (da) Tumorsuppressor designeret TS10Q23.3
ID17723A (id) Senyawa untuk pengobatan
IDP000008233A (id) Metode pencegahan kanker payudara
HUP0101947A3 (en) Combination for the treatment of tumors
DE69707726D1 (de) Auskleidung
MD798F1 (en) Method of the mamma cancer treatment
FI970717A0 (fi) Menetelmät kohtusyövän inhiboimiseksi
IT1294247B1 (it) Procedimento per la produzione di nitrobenzammidi oppure amminobenzammidi
GB9624800D0 (en) Methods of preventing breast cancer
KR970053540U (ko) 침시술용 침관
ZA979723B (en) Methods of preventing breast cancer.
BR9700778A (pt) Métodos de inibição de tumores do cólon
DE29614689U1 (de) Abstands-Schieblehre
FI2621U1 (fi) Jarrukilpi
SE9604154D0 (sv) Anticancer compounds
IT1282581B1 (it) Procedimento per la ramificazione controllata di poliolefine
IT1283281B1 (it) Procedimento per la ramificazione controllata di poliolefine